Edward Van Wezel

Edward Van Wezel serves as the Director at TigaTx since July 2020 and is the Founder and Managing Partner at BGV (BioGeneration Ventures) since 2006, specializing in venture capital for life sciences companies. Additional board roles include directorships at Confo Therapeutics, AZAFAROS B.V., and Scenic Biotech, all of which commenced between 2017 and 2019. Edward was also a founding investor and member of the supervisory board at Acerta Pharma B.V. from 2013 to 2016 and previously held the position of Managing Director at Macrozyme BV from 2001 to 2005, and Project Manager at Johnson & Johnson from 1997 to 2000. Edward Van Wezel's academic background includes studies at Utrecht University and Delft University of Technology.